deferiprone has been researched along with Glial Cell Tumors in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Iron chelators have been shown to have anti-tumor activity; however, deferiprone (DFP), an orally administered iron chelator, has not been previously evaluated in gliomas." | 7.83 | Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells. ( Alexiou, GA; Gerogianni, P; Kyritsis, AP; Vartholomatos, E, 2016) |
| " Iron chelators have been shown to have anti-tumor activity; however, deferiprone (DFP), an orally administered iron chelator, has not been previously evaluated in gliomas." | 3.83 | Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells. ( Alexiou, GA; Gerogianni, P; Kyritsis, AP; Vartholomatos, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexiou, GA | 1 |
| Gerogianni, P | 1 |
| Vartholomatos, E | 1 |
| Kyritsis, AP | 1 |
1 other study available for deferiprone and Glial Cell Tumors
| Article | Year |
|---|---|
Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Surv | 2016 |